Related Experiment Video

Updated: Jun 28, 2026

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

5.8K

Lipidomics-driven drug discovery and delivery strategies in glioblastoma

Xiaohui Weng1, Michael Gonzalez1, Jeannes Angelia1

  • 1Department of Chemistry and Biochemistry, California State University Fullerton, Fullerton, CA 92831, United States.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
|December 26, 2024
PubMed

Insights

Lipidomics offers new therapeutic strategies for glioblastoma (GBM) by targeting altered lipid metabolism. This approach aids in discovering biomarkers and improving drug delivery for this aggressive brain cancer.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Glioblastoma (GBM) remains a highly aggressive brain cancer with limited effective treatments.
  • Altered lipid metabolism is a hallmark of GBM, influencing tumor growth, survival, and treatment resistance.

Purpose of the Study:

  • To explore the role of lipidomics in understanding and targeting GBM.
  • To review lipidomics applications in biomarker discovery, drug development, and drug delivery for GBM.

Main Methods:

  • Comprehensive analysis of lipid profiles in GBM.
  • Review of lipid-targeted therapeutic strategies and drug delivery systems.
  • Integration of lipidomics with other omics technologies.

Main Results:

  • Lipidomics reveals critical insights into GBM's metabolic landscape.
  • Identification of potential lipid-based biomarkers for GBM diagnosis and prognosis.
  • Development of novel drug delivery systems targeting lipid pathways in GBM.

Conclusions:

  • Lipidomics presents a promising avenue for developing more effective GBM treatments.
  • Targeting lipid metabolism holds potential for overcoming GBM therapeutic resistance.
  • Integrating lipidomics with other omics enhances our understanding of GBM biology.
Keywords:
Drug deliveryGlioblastomaLipidomicsMulti-target Directed Ligands

More Related Videos

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.